Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Manufacturing
(263/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Novartis Pharmaceuticals Corporation
Feb 16, 2021
Novartis Entresto® granted expanded indication in chronic heart failure by FDA
Dec 09, 2020
Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer
Dec 07, 2020
Novartis and Amgen partner with Karamo Brown to support and empower people living with migraine
Dec 01, 2020
Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps
Nov 19, 2020
New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases
Nov 13, 2020
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17, regardless of age and gender
Nov 05, 2020
Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
Aug 20, 2020
FDA approves Novartis Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis
Aug 13, 2020
Novartis announces FDA filing acceptance of Xolair® (omalizumab) prefilled syringe for self-administration across all indications
Jul 01, 2020
Novartis Pharmaceuticals Agrees To Pay $678 Million To Settle Shepherd, Finkelman, Miller & Shah, LLP False Claims Act Qui Tam Case
May 06, 2020
Novartis announces FDA approval of MET inhibitor Tabrecta(TM) for metastatic non-small cell lung cancer with METex14
Mar 28, 2020
Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Mar 18, 2020
Novartis Recalls 100 mg Sandimmune and Neoral Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning
Mar 18, 2020
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy
Mar 18, 2020
Novartis Pharmaceuticals Corporation corrective action for certain blister packages of SANDIMMUNE® and NEORAL® 100-mg soft gelatin capsules in the US due to failure to meet child-resistant packaging requirements
Dec 11, 2019
Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps
Dec 04, 2019
First Industry Datasets Submitted to ASH Research Collaborative Data Hub
Nov 17, 2019
Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
Nov 15, 2019
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Oct 23, 2019
Multiple Sclerosis Association of America and Novartis Join Forces with TV Personality Montel Williams to Heighten Awareness of MS Progression through Storytelling
Page 1
››
Latest News
Apr 20, 2024
RMG Acquisition Corp. III Announces Cancellation of Dissolution
Apr 20, 2024
Bilateral Chamber Hosts Iraqi Prime Minister and his Delegation in Houston
Apr 20, 2024
Global Quantum Technology Market Research 2024-2029 with Assessment of Companies Focused on Quantum...
Apr 20, 2024
Eco Friendly Bottles Global Report 2024-2030: Edible Substitutes to Bottles Emerge as Potential Alternatives...
Apr 20, 2024
Global Needle Coke Market Analysis and Forecasts, 2023-2024 and 2033: Evolution in UHP Graphite Electrode...
Apr 20, 2024
Pure Spout Earns Industry Award for Best New Product
Apr 20, 2024
H2 Green Mining and Ohmium Sign Agreement to Boost Green Hydrogen in Chile
Apr 19, 2024
Churchill Serves as Sole Lead Arranger for a First Lien Credit Facility to Support Wynnchurch Capital’s...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events